MESO FY 2012 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena

MESOMesoblast Limited

$2B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38M-68.3% YoY

Gross Profit

$38M100.0% margin

Operating Income

-$49M-127.3% margin

Net Income

-$71M-185.9% margin

EPS (Diluted)

$-1.30

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$75M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$720M

Total Liabilities

$242M

Stockholders' Equity

$479M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$121M	-68.3%
Gross Profit	$38M	$121M	-68.3%
Operating Income	-$49M	$94M	-152.0%
Net Income	-$71M	$91M	-178.5%